“Tyrosine Kinase Inhibitors: New Molecules in Non-Small Cell Lung Cancer (EGFR AND ALK)”. ADMET and DMPK 5, no. 1 (March 24, 2017): 1–8. Accessed October 9, 2026. https://pub.iapchem.org/ojs/index.php/admet/article/view/352.